ERBB2 and breast carcinoma: Using the edgeR tool in the Galaxy platform, we analyzed the raw sequencing data from the RNA sequencing datasets GSE157383 [57] and GSE99060 [58] from the MDA-MB-453 (HER2+), MDA-MB-453 (HER2-), and MDA-MB-361 (HER2+) breast cancer cells treated ± abemaciclib [63].